No salesforce purge in Pfizer’s $4 billion cuts

April 7, 2005
Sales and Marketing

Pfizer has set out a $4 billion cost cutting programme for the next three years in an attempt to return …

New hepatitis B treatment approved in US

April 6, 2005
Sales and Marketing

Bristol-Myers Squibb has received US approval for its hepatitis B treatment Baraclude after a six-month priority review.Baraclude (entecavir) is BMS's …

Takeda abandons phase III diabetes drug

April 5, 2005
Research and Development

Takeda has been forced to abandon one of its lead pipeline products after a small number of patients in clinical …

Interactive sampling

April 4, 2005
Sales and Marketing

The internet has changed the way many of us live our lives, from grocery shopping to booking holidays, but can …

Government fails to meet GP recruitment target

March 31, 2005

The government has fallen short of recruiting its target number of new family doctors, despite figures showing an increase in …

Super surgeries spell big changes for patients and pharma

March 31, 2005

GPs will be given the freedom to carry out services traditionally only available in hospitals as the government unveiled plans …

And finally – the NSF for Long Term Conditions

March 31, 2005

The National Service Framework  for Long Term Conditions has been launched by the government, which has pledged that it will …

Renamed agency responds to pharma’s strategic aims

March 31, 2005
Medical Communications

Healthcare communications agency Brader Perryman has changed its name to Seven Stones, a move designed to reflect its diversity of …

Greater openness required by new European laws

March 31, 2005

Pharmaceutical companies will be obliged to share safety data more openly from November with the adoption of new pan-European laws.The …

Europe unaffected by GSK’s manufacturing problems

March 31, 2005
Sales and Marketing

Batches of GlaxoSmithKline's diabetes treatment Avandamet and depression treatment Paxil CR have been seized in the US due to continuing …

New drug applications to keep rising, European regulator says

March 31, 2005
Sales and Marketing

The EMEA says it received 51 new drug applications in 2004, a figure which represents a significant rise over the …

Industry heads speak out against new European hurdle

March 31, 2005
Sales and Marketing

Two leading pharmaceutical executives have criticised European regulators for demanding that new treatments be compared with existing drugs before they …

Stroke audit uncovers alarming variation in medication in UK

March 30, 2005

An in-depth audit of services for stroke patients shows standards of care are generally improving – but progress is slow …

Finding the right NHS partner

March 23, 2005

Pharma companies want to work with the NHS and the NHS wants to work with pharma companies. There is lots …

The Gateway to Local Adoption Series

Latest content